These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24290338)

  • 21. ECT: lay attitudes and experiences--a pilot study.
    O'Shea B; McGennis A
    Ir Med J; 1983 Jan; 76(1):40-3. PubMed ID: 6826340
    [No Abstract]   [Full Text] [Related]  

  • 22. The impact of health technology assessment reports on decision making in Austria.
    Zechmeister I; Schumacher I
    Int J Technol Assess Health Care; 2012 Jan; 28(1):77-84. PubMed ID: 22233544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research and development on a public attitude instrument for stuttering.
    St Louis KO
    J Commun Disord; 2012; 45(2):129-46. PubMed ID: 22205037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using willingness to pay to assess the benefits of assisted reproductive techniques.
    Ryan M
    Health Econ; 1996; 5(6):543-58. PubMed ID: 9003941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technology assessment: approach and reimbursement.
    Yaszemski MJ; Polly DW; Boden SD; Andersson GB
    Spine (Phila Pa 1976); 2007 May; 32(11 Suppl):S39-43. PubMed ID: 17495585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide.
    Diaby V; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):81-99. PubMed ID: 24328890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The psychosocial implications of live-related kidney donation.
    Eggeling C
    EDTNA ERCA J; 1999; 25(3):19-22. PubMed ID: 10786489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions?
    Greenberg D; Neumann PJ
    Expert Rev Pharmacoecon Outcomes Res; 2011 Feb; 11(1):113-9. PubMed ID: 21351863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Objectivity of reimbursement decisions - does it always has to pay off?
    Kolasa K
    Przegl Epidemiol; 2013; 67(3):503-7, 599-603. PubMed ID: 24340569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence-based decision-making and health technology assessment in South Korea.
    Park SH; Lee SM
    Value Health; 2008 Mar; 11 Suppl 1():S163-4. PubMed ID: 18387062
    [No Abstract]   [Full Text] [Related]  

  • 31. Public attitudes regarding willingness to participate in medical research studies.
    Trauth JM; Musa D; Siminoff L; Jewell IK; Ricci E
    J Health Soc Policy; 2000; 12(2):23-43. PubMed ID: 11184441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries.
    Kolasa K; Kalo Z; Zah V; Dolezal T
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):283-7. PubMed ID: 22812552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Access with evidence development schemes: a framework for description and evaluation.
    McCabe CJ; Stafinski T; Edlin R; Menon D;
    Pharmacoeconomics; 2010; 28(2):143-52. PubMed ID: 20085390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-quality trade-offs in dialysis care: a national survey of dialysis facility administrators.
    Powe NR; Thamer M; Hwang W; Fink NE; Bass EB; Sadler JH; Levin NW
    Am J Kidney Dis; 2002 Jan; 39(1):116-26. PubMed ID: 11774110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Financing of certified centers: a willingness-to-pay analysis.
    Thiel FC; Scharl A; Hildebrandt T; Kotziabassis E; Schrauder MG; Bani MR; Müller A; Hauzenberger T; Loehberg CR; Jud SM; Fasching PA; Hartmann A; Schulz-Wendtland R; Strnad V; Beckmann MW; Lux MP
    Arch Gynecol Obstet; 2013 Mar; 287(3):495-509. PubMed ID: 23080545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. To be involved or not to be involved: a survey of public preferences for self-involvement in decision-making involving mental capacity (competency) within Europe.
    Daveson BA; Bausewein C; Murtagh FE; Calanzani N; Higginson IJ; Harding R; Cohen J; Simon ST; Deliens L; Bechinger-English D; Hall S; Koffman J; Ferreira PL; Toscani F; Gysels M; Ceulemans L; Haugen DF; Gomes B;
    Palliat Med; 2013 May; 27(5):418-27. PubMed ID: 23426845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The artificial womb: a pilot study considering people's views on the artificial womb and ectogenesis in Israel.
    Simonstein F; Mashiach-Eizenberg M
    Camb Q Healthc Ethics; 2009; 18(1):87-94. PubMed ID: 19091150
    [No Abstract]   [Full Text] [Related]  

  • 38. Chance of reimbursement for ADD-ON therapies in Poland and in the world - review of the reimbursement recommendations.
    Borowiack E; Marzec M; Nowotarska A; Jarosz J; Orkisz A; Prząda-Machno P
    Przegl Epidemiol; 2018; 72(1):99-109. PubMed ID: 29667385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding public preferences for prioritizing health care interventions in England: does the type of health gain matter?
    Mason H; Baker R; Donaldson C
    J Health Serv Res Policy; 2011 Apr; 16(2):81-9. PubMed ID: 21447843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding attitudes toward clinical research.
    Schulman KA
    J Ambul Care Manage; 2003; 26(1):88-90. PubMed ID: 12545518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.